Gabitril - Supply Issues Resolved

Further to our recent news items towards the tail-end of 2019 regarding the supply of Gabitril 5mg, 10mg & 15mg, we can confirm that the supply issues experienced have now been resolved following further communication from the drug's manufacturer TEVA. 

Furthermore, the HPRA have confirmed that delivery received should be enough to meet patient demand for all of 2020 and therefore no further supply issues are envisaged for the upcoming year.

We would like to thank the HPRA and TEVA for working with Epilepsy Ireland regarding this shortage and for providing further information wherever possible.